Essure

Shook Taps Partner to Lead New Litigation Strategy Practice Focusing on Co-Counsel Collaboration

Retrieved on: 
Thursday, February 8, 2024
Shook, Hardy & Bacon, MDL, Virtual law firm, Partnership, Ranitidine, Docetaxel, Judicial panel, Product liability, Essure, Lawyer, Ondansetron, CLSC, VLF, Motion

WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Trial and litigation firm Shook, Hardy & Bacon has named Partner Jennifer Stevenson as co-chair of its newly formed Complex Litigation Strategic Counseling (CLSC) Practice, alongside Partner Patrick Oot. This cross disciplinary group includes the firm's Chambers-ranked Discovery Strategies Practice, which will continue to provide creative and defensible discovery solutions, while offering an array of new strategic counseling services to clients navigating the coordination challenges of mass torts and multidistrict litigation.

Key Points: 
  • WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Trial and litigation firm Shook, Hardy & Bacon has named Partner Jennifer Stevenson as co-chair of its newly formed Complex Litigation Strategic Counseling (CLSC) Practice, alongside Partner Patrick Oot .
  • "Our Complex Litigation Strategic Counseling Practice offers clients a holistic approach to effectively and efficiently manage multidistrict litigation," said Stevenson.
  • Her litigation successes include pioneering the motion to dismiss and show cause strategy in the In re Zofran (Ondansetron) Products Liability Litigation MDL.
  • "Shook's long history as strategic coordinating counsel in MDLs, mass torts and complex litigation is second to none," said Shook Chair Madeleine McDonough .

FDA Roundup: October 31, 2023

Retrieved on: 
Tuesday, October 31, 2023
Cream, Ice cream, FDA, Steris, Food, Ethylene oxide, Vaccine, Listeria monocytogenes, Cisplatin, Human services, Infection, News, Medical device, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PMA, HIV disease progression rates, Cosmetics, NPC, Soft serve, Multimedia, Dietary supplement, Environment, Nasopharyngeal carcinoma, Disease, Radiation, EO, Sterilization, Public, House, Woman, Safety, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Office of Inspector General, U.S. Department of Health and Human Services, Patient, Heated tobacco product, China Biologic Products, Animal, Essure

The FDA remains committed to collecting and providing updates on the long-term safety and effectiveness information about Essure, a permanently implanted birth control device for women.

Key Points: 
  • The FDA remains committed to collecting and providing updates on the long-term safety and effectiveness information about Essure, a permanently implanted birth control device for women.
  • Although Essure has not been available for implantation in the United States since December 2019, the FDA continues to monitor the product's safety through an FDA-required postmarket surveillance ("522") study and other activities.
  • The master file was submitted by Steris Corporation, Sterilization for Medical Devices | FDA .
  • The FDA also approved toripalimab-tpzi as a single agent for adults with recurrent unresectable or metastatic NPC with disease progression on or after a platinum-containing chemotherapy.

Breaking News: Judge in J&J Talc Baby Powder Lawsuit Unexpectedly Halts All Trials

Retrieved on: 
Tuesday, April 25, 2023
J&J, Johnson & Johnson, Ovarian cancer, Talc, Bankruptcy, Lawyer, Injury, Essure, Pharmaceutical industry, Insurance, Tobacco

TRENTON, N.J., April 25, 2023 /PRNewswire/ -- Legal Bay, the pre settlement funding company, reports a major announcement in the decades-long litigation against Johnson & Johnson from the over 80K victims who claim their ovarian cancer was directly caused by J&J's talcum-based baby powder product. Last week, U.S. Bankruptcy Judge Michael Kaplan abruptly ruled that all J&J trials will be put on hold as he considers the pharmaceutical giant's second attempt at bankruptcy. The situation lends credence to claims from plaintiff's lawyers that J&J is attempting to inadequately compensate the victims in these cases. Despite the $9BB settlement offer and a North American recall, the New Jersey-based company continues to insist their product is safe.

Key Points: 
  • Last week, U.S. Bankruptcy Judge Michael Kaplan abruptly ruled that all J&J trials will be put on hold as he considers the pharmaceutical giant's second attempt at bankruptcy.
  • The situation lends credence to claims from plaintiff's lawyers that J&J is attempting to inadequately compensate the victims in these cases.
  • Legal-Bay is an industry leader in mass tort funding and one of the only companies even considering Talc cases currently.
  • The non-recourse funding, also referred to as a lawsuit loan or lawsuit loans by clients, are risk-free.

Legal-Bay Pre-Settlement Funding Announces Johnson & Johnson to Pay Out $8.9 BILLION in Damages to Plaintiffs in Talcum Powder Lawsuit

Retrieved on: 
Thursday, April 6, 2023
J&J, Johnson & Johnson, Ovarian cancer, Safety, Inferior vena cava, Lawyer, Roundup, Risk, Personal injury, Tobacco, Insurance, Essure

NEW BRUNSWICK, N.J., April 6, 2023 /PRNewswire/ -- Legal-Bay LLC, the premier Pre Settlement Funding Company, reports that Johnson & Johnson will pay out a whopping $8.9BB in damages to settle the 60,000+ lawsuits brought against them by plaintiffs who claim the baby powder is directly to blame for their ovarian cancer. The pharma giant previously proposed a $2BB settlement, but with this latest 8.9BB offering hopes to close out their legal troubles once and for all.

Key Points: 
  • The pharma giant previously proposed a $2BB settlement, but with this latest 8.9BB offering hopes to close out their legal troubles once and for all.
  • The company has long been aware of the health risks associated with their talcum-based baby powder.
  • However, our sources representing plaintiffs do not believe the $150K average talc settlement amount is sufficient based on the damages.
  • Legal-Bay's lawsuit funding programs are designed to provide immediate cash in advance of a plaintiff's anticipated monetary award.

Baron & Budd Attorney Recognized with National Civil Justice Award

Retrieved on: 
Wednesday, December 21, 2022
Professional Services, Philanthropy, Legal, Other Philanthropy, Foundation, Consulting, Inferior vena cava, P.C, Weitz & Luxenberg P.C., Twenty-seventh Amendment of the Constitution of Ireland, Milestone, Antibiotic sensitivity testing, Trauma, Baron & Budd, P.C., Lawyer, Human, Seventh Amendment, Stress incontinence, Pharmaceutical industry, Insurance, Talc, Essure

In its inaugural year, this distinction is awarded annually by The Milestone Charitable Foundation to a select group of lawyers across the country who are innovative in their pursuit of justice.

Key Points: 
  • In its inaugural year, this distinction is awarded annually by The Milestone Charitable Foundation to a select group of lawyers across the country who are innovative in their pursuit of justice.
  • Compassionate Counsel recipients are selected by The Milestone Foundation’s board for their unwavering commitment to the tenets of the Seventh Amendment and belief in the fundamental right to justice.
  • These lawyers work tirelessly to help victims of civil injustices receive their rightful compensation and avoid additional harm or trauma throughout the course of their lawsuit.
  • Since joining Baron & Budd, Ms. Rol has worked on a variety of pharmaceutical cases, including Transvaginal Mesh, Fluoroquinolone Antibiotics, Xarelto, IVC Filter, Essure, and Talcum litigation.

Bayer Announces Resolution of U.S. Essure™ Claims

Retrieved on: 
Thursday, August 20, 2020
Legal, Medical devices, Women, Professional services, Other Health, Health, Consumer, Pharmaceutical, General Health, Companies, Industries, Essure, Medical technology, Sterilization, Bayer, Life sciences

Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S. Essure claims involving women who allege device-related injuries.

Key Points: 
  • Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S. Essure claims involving women who allege device-related injuries.
  • The company will pay approximately 1.6 billion U.S. dollars (1.35 billion euros) to resolve these claims, including an allowance for outstanding claims, and is in resolution discussions with counsel for the remaining plaintiffs.
  • Bayer will continue to provide support services for women with Essure and their healthcare providers.
  • Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world.

Legal-Bay Pre-Settlement Funding Announces Updates to Essure Lawsuits

Retrieved on: 
Wednesday, July 8, 2020
Sterilization, Essure, Companies, Industries, Legal financing, Bayer, Articles

PHILADELPHIA, July 8, 2020 /PRNewswire/ -- Legal-Bay LLC, The Pre-Settlement Funding Company, announced their renewed commitment to assisting the many victims who've filed Essure Birth Control lawsuits, and are hoping for presettlement payouts despite court delays.

Key Points: 
  • PHILADELPHIA, July 8, 2020 /PRNewswire/ -- Legal-Bay LLC, The Pre-Settlement Funding Company, announced their renewed commitment to assisting the many victims who've filed Essure Birth Control lawsuits, and are hoping for presettlement payouts despite court delays.
  • The Essure brand birth control device is put out by Bayer, who is accused of knowingly distributing a faulty product.
  • More than 32,000 plaintiffs have claimed serious pain and suffering from broken devices including device migration and perforated organs.
  • All of Legal-Bay funding programs are risk-free as you only repay the advance if your case is successful.

Legal-Bay Pre Settlement Funding Preparing For Numerous Bayer Lawsuits

Retrieved on: 
Saturday, November 9, 2019
Articles, Economy, Sterilization, Essure, Business, Lawsuits, Legal costs, Bayer, Legal financing, Nonrecourse debt

JERSEY CITY, N.J., Nov. 9, 2019 /PRNewswire/ --Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they have recently seen an increase in Essure birth control lawsuits, and are preparing for numerous presettlement payouts in the coming months.

Key Points: 
  • JERSEY CITY, N.J., Nov. 9, 2019 /PRNewswire/ --Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they have recently seen an increase in Essure birth control lawsuits, and are preparing for numerous presettlement payouts in the coming months.
  • The Essure brand birth control device is put out by Bayer, who is accused of knowingly distributing a faulty product.
  • More than 17,000 plaintiffs have claimed serious pain and suffering from broken devices including device migration and perforated organs.
  • The non-recourse advance is not a lawsuit loan, lawsuit loans, pre settlement loan, or pre-settlement loans.

Legal-Bay Pre Settlement Funding Preparing For Numerous Bayer Lawsuits

Retrieved on: 
Monday, July 22, 2019
Articles, Economy, Sterilization, Business, Essure, Lawsuits, Legal costs, Legal financing, Nonrecourse debt, Bayer

JERSEY CITY, N.J., July 22, 2019 /PRNewswire/ --Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they have recently seen an increase in Essure birth control lawsuits, and are preparing for numerous presettlement payouts in the coming months.

Key Points: 
  • JERSEY CITY, N.J., July 22, 2019 /PRNewswire/ --Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they have recently seen an increase in Essure birth control lawsuits, and are preparing for numerous presettlement payouts in the coming months.
  • The Essure brand birth control device is put out by Bayer, who is accused of knowingly distributing a faulty product.
  • More than 17,000 plaintiffs have claimed serious pain and suffering from broken devices including device migration and perforated organs.
  • The non-recourse advance is not a lawsuit loan, lawsuit loans, pre settlement loan, or pre-settlement loans.

Bayer Fact Checks Netflix's The Bleeding Edge

Retrieved on: 
Friday, July 27, 2018
Ethics, Economy, Applied ethics, Essure, Sterilization, Bayer, Heroin, Corporate social responsibility

Bayer also is reminding women with Essure that the safety profile of the device remains positive and unchanged.

Key Points: 
  • Bayer also is reminding women with Essure that the safety profile of the device remains positive and unchanged.
  • In contrast, the portrayal of Essure in The Bleeding Edge lacks scientific support, despite the fact that Bayer provided the producers with extensive scientific information on Essure before the completion of the film.
  • Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.
  • Bayer and the Bayer Cross are registered trademarks of Bayer.